SUZUKEN : Notice Regarding Acquisition of Treasury Shares by Own Share Repurchase Trading (ToSTNeT-3) (Acquisition of treasury shares in accordance with the Articles of Incorporation pursuant to the provision of Article 459, Paragraph 1 of the Companies Act)
June 01, 2017 at 08:06 pm EDT
Share
Press Release Suzuken Co., Ltd.
Hiromi Miyata, President and CEO (Stock Code: 9987)
May 15, 2017
Securities Traded: First Sections of the Tokyo and Nagoya Stock Exchanges and the Sapporo Securities Exchange
Contact: Shigeru Asano, Director and Senior Executive Officer; Senior General Manager, Corporate Management Headquarters
Tel.: +81-52-961-2331
Notice Regarding Acquisition of Treasury Shares by Own Share Repurchase Trading (ToSTNeT-3) (Acquisition of treasury shares in accordance with the Articles of Incorporation pursuant to the provision of Article 459, Paragraph 1 of the Companies Act)
Suzuken Co., Ltd. (hereinafter the "Company") announced today that it has decided the specific method for an acquisition of treasury shares in accordance with the Articles of Incorporation pursuant to the provision of Article 459, Paragraph 1 of the Companies Act, items pertaining to which were resolved by the Board of Directors on May 11, 2017. Details are as follows.
Method of Acquisition
The Company will place an order to purchase shares at 8:45 a.m. on May 16, 2017 through the own share repurchase trading (ToSTNeT-3) of Tokyo Stock Exchange, Inc. The acquisition price will be the closing price of the Company's shares today (May 15, 2017), ¥3,570. (This will not be changed to another transaction system or time). The buy-order will be placed only at this time.
Acquisition Details
Type of Shares to Be Acquired Shares of common stock
Number of Shares to Be Acquired 2,200,000 shares
Announcement of Acquisition Result The acquisition result will be announced after the transaction is complete at 8:45 a.m.
(Notes) 1. The number of shares to be acquired will not be changed. However, it is possible that some or all of the shares will not be acquired due to market fluctuations, etc.
2. The repurchase will be conducted based on buy-orders corresponding to the planned number of shares to be acquired.
(Reference) Details of Resolution to Acquire Treasury Shares (Announced on May 11, 2017)
Type of Shares to Be Acquired Shares of common stock
Number of Shares to Be Acquired 2,200,000 shares (upper limit)
(Ratio of total number of issued shares (excluding treasury shares) 2.28%)
Total Amount of the Acquisition Price of the Shares ¥8.5 billion (upper limit)
Acquisition Period May 15, 2017 to June 30, 2017
Suzuken Co. Ltd. published this content on 15 May 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 02 June 2017 00:06:17 UTC.
Original documenthttp://v4.eir-parts.net/v4Contents/View.aspx?template=announcement&sid=36334&code=9987
Public permalinkhttp://www.publicnow.com/view/5EF862FACF3DB55156846E81D637D016131CFC23
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
SUZUKEN : Notice Regarding Acquisition of Treasury Shares by Own Share Repurchase Trading (ToSTNeT-3) (Acquisition of treasury shares in accordance with the Articles of Incorporation pursuant to the provision of Article 459, Paragraph 1 of the Companies Act)